Filtros de búsqueda

Lista de obras de Borwin Bandelow

30 Jahre Erfahrung mit Haloperidol

artículo científico publicado en 1991

5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo

artículo científico publicado en 2003

A 2010 evidence-based algorithm for the pharmacotherapy of social anxiety disorder

artículo científico publicado en 2010

A randomized, controlled trial of aerobic exercise in combination with paroxetine in the treatment of panic disorder

artículo científico publicado en 2010

Adenosine A(2A) receptor gene: evidence for association of risk variants with panic disorder and anxious personality

artículo científico publicado en 2010

An international survey of reported prescribing practice in the treatment of patients with generalised anxiety disorder

artículo científico publicado en 2011

Application of a new statistical approach to evaluate a clinical trial with panic disorder patients

artículo científico publicado en 1999

Assessing the efficacy of treatments for panic disorder and agoraphobia. I. Methodological problems

Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale

article by Borwin Bandelow published June 1995 in International Clinical Psychopharmacology

Association analysis of Rgs7 variants with panic disorder

artículo científico publicado en 2008

Association of polymorphisms in the angiotensin-converting enzyme gene with syndromal panic attacks

article

Attachment style, anxiety coping, and personality-styles in withdrawn alcohol addicted inpatients

artículo científico publicado en 2013

Atypical Anorexia in a Male Patient Accompanied by Strong Obsessive-compulsive Symptoms Successfully Treated with Naltrexone

artículo científico publicado en 2009

Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis

scientific article published on 20 November 2018

Bedeutung des zentralen Serotoninsystems bei Alkoholabhängigkeit und therapeutische Konsequenzen

scientific article published on 01 October 1998

Biological markers for anxiety disorders, OCD and PTSD - a consensus statement. Part I: Neuroimaging and genetics

artículo científico publicado en 2016

Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition

artículo científico publicado en 2016

Blood dyscrasias induced by psychotropic drugs.

artículo científico publicado en 2004

Borderline personality disorder: a dysregulation of the endogenous opioid system?

artículo científico publicado en 2010

C.10.01 Generalized anxiety disorder (GAD): the treatment implications of clinical heterogeneity

Cardio-respiratory and other symptom clusters in panic disorder

artículo científico publicado en 1996

Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants.

artículo científico publicado en 2008

Clinically relevant drug interactions in anxiety disorders

artículo científico

Clozapine-associated elevation of plasma cholinesterase

artículo científico publicado en 2001

Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder

artículo científico publicado en 2008

Comparison of the DSM-5 and ICD-10: panic and other anxiety disorders

artículo científico publicado en 2017

Correspondence (reply): In reply

DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences--part 1: general aspects and paradigmatic discussion of depressive disorders

artículo científico

DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders,

artículo científico publicado en 2014

Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners

artículo científico publicado en 1999

Depressive syndromes in schizophrenic patients after discharge from hospital. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich

artículo científico publicado en 1990

Depressive syndromes in schizophrenic patients under neuroleptic therapy

artículo científico publicado en 1992

Die soziale Angststörung – Diagnostik und Behandlungsmöglichkeiten

artículo científico publicado en 2008

Diurnal variation of cortisol in panic disorder

artículo científico publicado en 2000

Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with borderline personality disorder and healthy controls.

artículo científico publicado en 2005

Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with depressive disorder and healthy controls

artículo científico publicado en 2012

Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder

artículo científico publicado en 2002

Early traumatic life events, parental rearing styles, family history of mental disorders, and birth risk factors in patients with social anxiety disorder

artículo científico publicado en 2004

Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects

artículo científico publicado en 2001

Effects of hypnotics on sleep quality and daytime well-being. Data from a comparative multicentre study in outpatients with insomnia

artículo científico publicado en 1995

Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: an analysis of pooled data from three 8-week placebo-controlled studies

artículo científico publicado en 2011

Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial

artículo científico publicado en 2009

Efficacy of treatments for anxiety disorders: a meta-analysis

artículo científico publicado en 2015

Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity

artículo científico publicado en 2019

Empfehlungen für die Verwendung von Meßinstrumenten in der klinischen Angstforschung

Endurance Training in Panic Patients: Spiroergometric and Clinical Effects

artículo científico publicado en 1998

Escitalopram in the treatment of anxiety symptoms associated with depression

artículo científico publicado en 2007

Etiology of initially unexplained confusion of excitability in deadly nightshade poisoning with suicidal intent. Symptoms, differential diagnosis, toxicology and physostigmine therapy of anticholinergic syndrome

artículo científico publicado en 2000

Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies

artículo científico publicado en 2013

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

artículo científico publicado en 2005

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology.

artículo científico publicado en 2014

Exercise Avoidance and Impaired Endurance Capacity in Patients with Panic Disorder

artículo científico publicado en 1997

Extended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baseline

artículo científico publicado en 2014

Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study

artículo científico publicado en 2009

FC04.01 Responsiveness of central serotonin receptors in panic disorder: Effects of clomipramine treatment and exercise

scholarly article by A. Broocks et al published October 2000 in European Psychiatry

Fluvoxamine or Placebo in the Treatment of Panic Disorder and Relationship to Blood Concentrations of Fluvoxamine

article

Functional MRI activation in response to panic-specific, non-panic aversive, and neutral pictures in patients with panic disorder and healthy controls

artículo científico publicado en 2015

Gender differences in associations of glutamate decarboxylase 1 gene (GAD1) variants with panic disorder

artículo científico publicado en 2012

Generalized Anxiety Disorder and Pain

artículo científico

Grey matter structural differences in alcohol-dependent individuals with and without comorbid depression/anxiety-an MRI study.

artículo científico publicado en 2018

Guideline-oriented inpatient psychiatric psychotherapeutic/psychosomatic treatment of anxiety disorders : How many personnel are need?

artículo científico publicado en 2016

Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care

artículo científico publicado en 2012

How are symptom severity and functional recovery/relapse related? An analysis of the escitalopram database

How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database

artículo científico publicado en 2009

How to grade categories of evidence.

artículo científico publicado en 2008

Impaired perceptual processing and conceptual cognition in patients with anxiety disorders: a pilot study with the binocular depth inversion paradigm

artículo científico publicado en 2012

Improvement of Quality of Life in Panic Disorder with Escitalopram, Citalopram, or Placebo

artículo científico publicado en 2007

Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder

artículo científico publicado en 2000

Insertion/deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: A gender-specific effect?

article

Koinzidenz von Angst- und Schlafstörungen

artículo científico publicado en 1996

Long term treatment of anxiety disorders

Manifesto for a European anxiety disorders research network

artículo científico publicado en 2010

Mean age and gender distribution of patients with major mental disorders participating in clinical trials

artículo científico publicado en 2019

Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders

article

Myocarditis associated with clozapine treatment

Myocarditis associated with clozapine treatment

scientific article published on 01 October 2000

Network analyses to rank pharmacological treatments for generalised anxiety disorder

artículo científico publicado en 2019

Neue Antidepressiva im Vergleich zu klassischen Trizyklika - Wirkmechanismen und klinische Beurteilung -

scientific article published on 01 January 2000

Neuroimaging in anxiety disorders

scholarly article by Kirsten Engel et al published 1 June 2009 in Journal of Neural Transmission

Neuropeptide S receptor gene -- converging evidence for a role in panic disorder

artículo científico publicado en 2010

Neuropsychiatrische Erkrankungen und Demenzen: ein interdisziplinärer Ansatz

Nocturnal Melatonin Secretion and Sleep after Doxepin Administration in Chronic Primary Insomnia

artículo científico publicado en 1996

Nocturnal plasma melatonin levels after flunitrazepam administration in healthy subjects

artículo científico publicado en 1996

Nocturnal plasma melatonin levels in patients suffering from chronic primary insomnia

artículo científico publicado en 1995

Nocturnal urinary cortisol excretion over a randomized controlled trial with paroxetine vs. placebo combined with relaxation training or aerobic exercise in panic disorder.

artículo científico publicado en 2008

P.4.d.002 Which factors predict placebo response in anxiety disorders and major depression?

article

Panic disorder during pregnancy and postpartum period

artículo científico publicado en 2006

Panic disorder — acceptance of the diagnostic entity and treatment modalities preferred by German health professionals

article

Panikstörung und Agoraphobie: Was wirkt?

artículo científico publicado en 1995

Parallel increase of heterochromatic increment threshold and postadaptation thresholds in Parkinson's disease and in neuroleptic treatment

artículo científico publicado en 1997

Pharmacological treatment of anxiety disorders - is there a state of the art?

scholarly article by Borwin Bandelow published March 2007 in European Psychiatry

Pharmakotherapie bei Persönlichkeitsstörungen

artículo científico publicado en 2005

Plasma homocysteine is a predictor of alcohol withdrawal seizures

artículo científico publicado en 2000

Polymorphism of the gene of angiotensin converting enzyme: lack of association with mood disorder

article

Possible role of a dysregulation of the endogenous opioid system in antisocial personality disorder

artículo científico

Posttraumatic stress disorder (PTSD) in the German Armed Forces: a retrospective study in inpatients of a German army hospital

artículo científico publicado en 2012

RGS2 ggenetic variation: association analysis with panic disorder and dimensional as well as intermediate phenotypes of anxiety

artículo científico publicado en 2015

Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia

artículo científico publicado en 2005

Randomized, double-blind study of SR142801 (Osanetant). A novel neurokinin-3 (NK3) receptor antagonist in panic disorder with pre- and posttreatment cholecystokinin tetrapeptide (CCK-4) challenges

artículo científico publicado en 2005

Rebound insomnia after hypnotic withdrawal in insomniac outpatients

artículo científico publicado en 1998

Remission of acute psychotic anxious depression in a patient with Parkinson's disease after treatment with quetiapine

artículo científico publicado en 2009

Rgs 2 gene polymorphisms as modulators of anxiety in humans?

artículo científico publicado en 2006

S.2.6 Treatment of anxiety disorders

S.21.01 Treatment-resistant panic anxiety disorder

Safety and tolerance of zolpidem in the treatment of disturbed sleep

Salivary Cortisol in Panic Attacks

artículo científico publicado en 2000

Salivary, total plasma and plasma free cortisol in panic disorder

artículo científico publicado en 2000

Serotonergic function, substance craving, and psychopathology in detoxified alcohol-addicted males undergoing tryptophan depletion

artículo científico publicado en 2010

Sertraline and exposure therapy in social phobia

artículo científico publicado en 2004

Soziale Phobie

artículo científico publicado en 2014

TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies

artículo científico publicado en 2010

The German guidelines for the treatment of anxiety disorders

artículo científico publicado en 2014

The Use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial1

artículo científico publicado en 2000

The alpha2delta subunit of the voltage-dependent calcium channel. A new pharmaceutical target for psychiatry and neurology

artículo científico publicado en 2005

The best next drug in the course of generalized anxiety disorders: the "PN-GAD-algorithm".

artículo científico publicado en 2013

The diagnosis and treatment of generalized anxiety disorder

artículo científico publicado en 2013

The diagnosis of and treatment recommendations for anxiety disorders

artículo científico publicado en 2014

The quantification inventory for somatoform syndromes (QUISS): a novel instrument for the assessment of severity

artículo científico publicado en 2007

The relevance of 'mixed anxiety and depression' as a diagnostic category in clinical practice

artículo científico publicado en 2016

The use of parametric vs. nonparametric tests in the statistical evaluation of rating scales.

artículo científico publicado en 1998

The use of the Panic and Agoraphobia Scale in a clinical trial

artículo científico publicado en 1998

Urinary Excretion of Cortisol, Norepinephrine, Testosterone, and Melatonin in Panic Disorder

artículo científico publicado en 1997

WFSBP guidelines on how to grade treatment evidence for clinical guideline development

article

What treatments do patients with panic disorder and agoraphobia get?

artículo científico publicado en 1995

Wirksamkeitsuntersuchungen in der Psychotherapieforschung

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders

artículo científico publicado en 2002

Zur sozialen Situation schizophrener Patienten

scientific article published on 01 March 1998

[Erratum to: Guideline-oriented inpatient psychiatric psychotherapeutic/psychosomatic treatment of anxiety disorders. How many personnel are need?]

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda